Source: Beijing News
Author: Luo Zhihua
According to Red Star News, after the sales of Lianhua Qing Plague and Blood Oxygen instrument have been hot, the information on the purchase of "human immunoglobulin" has recently appeared on major social platforms.Family members of the critical patients stated on their personal social platform that some doctors suggested that the buyer immunoglobulin and contacted the pharmaceutical company to find out that there was a shortage of stock.
Human immunoglobulin has always had a relatively fixed legitimate demand.For example, patients with severe bacteria or virus infections, close contact with viral hepatitis, elderly patients with low immunity and severe disease, and newborn sepsis, etc., on the basis of other treatment, sometimes need to categorize immunogenic galcinAs auxiliary treatment methods, temporarily improve the body's immunity.
This is not only to patients with other diseases, but a few patients with crown diseases also have greater demand for human immunoglobulin.In addition to the immunogenic protein in the heavy and dangerous type, patients with high risk, high virus load, and rapid development of patients are also applicable.In fact, the immunoglobulin has been included in the recommendation list of crown disease treatment related drugs by Guangdong and other places.
But the misunderstanding of human immunoglobulin has always existed to varying degrees.The poor resistance is required to be immunoglobulin. If you want to go to the hospital, you want to go to the hospital to hang a few bottles of amino acids and protein, and require a few bottles of white protein. It is a typical manifestation of treating diseases as "tonic".
Some people believe that since the main role of human immunoglobulin is to improve immunity, perhaps for crown disease infection, it can play a role in disease prevention and disease.
The misunderstanding is that even if the immunoglobulin is used to treat the new crown infection, there must be indications, and there are corresponding clinical indications.In other words, human immunoglobulin is only applicable to patients with specific or severe crown diseases, and it is by no means a commonplace.
The bigger misunderstanding is that although it is proposed in the new type of coronary virus pneumonia diagnosis and treatment plan (trial ninth edition), the COVID-19 immunoglobulin can be used for some patients using COVID-19 immunoglobulin.Protein is specifically infected with coronary diseases, while human immunoglobulin is not specific.This is like ordinary antiviral drugs are invalid for coronary infections. Only drugs such as PAXLOVID are specially targeted at coronal virus.
The drug is not right, the prevention and treatment effect belongs to the virtuality, but the side effects and adverse reactions are often not absent.Entering the human body as a migrant -alien protein, sometimes it can interfere with the formation of its own antibodies, making it difficult for autoimmunity to establish it.Therefore, for people with normal immunity, human immunoglobulin seems to help in the short term, but in the long run, it may help.
Human immunoglobulin is both prescription and also blood products, and there is no risk of unprecedented sales and abuse.For example, as a blood product, human immunoglobulin is prone to allergic reactions during the infusion.In addition, blood products cannot be sold through network channels. Buying such specialized medicines on social platforms will also face greater legal risks.
